Imatinib Mesylate

CAS 220127-57-1 24 current records 7 historicalSmall Molecule

Who holds supplier records for Imatinib Mesylate? 24 organisations hold a current record for Imatinib Mesylate: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 17 of them hold a valid EU Certificate of Suitability (18 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (15), China (3), Italy (1), Netherlands (1) and 1 other country (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Imatinib Mesylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/imatinib-mesylate

Reading the evidence

  • 24 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    15 of the 21 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 19 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (24)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Imatinib Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India15China3Italy1Netherlands1Taiwan1Country not recorded for 3
  • FIS FABBRICA ITALIANA SINTETICI SPA
    Active DMF 25205, 25206 · latest filing Jul 2011
    ItalyCEP Company GMP cert on record
  • Hetero Labs Limited
    Active DMF 26687, 25116, 30960 · latest filing Sept 2016
    IndiaCEP Company GMP cert on record
  • Laurus Labs Limited
    Active DMF 27089, 33312 · latest filing Nov 2018
    IndiaCEP Company GMP cert on record
  • MSN Laboratories Private Limited
    Active DMF 26386, 32394 · latest filing Dec 2017
    IndiaCEP Company GMP cert on record
  • SHILPA PHARMA LIFESCIENCES LTD
    Active DMF 27927, 28349 · latest filing Jun 2014
    IndiaCEP
  • Zydus Lifesciences Limited
    Active DMF 34476, 30871 · latest filing Dec 2019
    India Company GMP cert on record
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 36238 · latest filing Aug 2021
    IndiaCEP Company GMP cert on record
  • Cipla Limited
    Active DMF 26170, 28333 · latest filing Jun 2014
    IndiaCEP Company GMP cert on record
  • Natco Pharma
    Active DMF 20410 · latest filing Apr 2007
    IndiaCEP Company GMP cert on record
  • Shandong Anxin Pharmaceutical Co., Ltd.
    Active DMF 29656 · latest filing Aug 2015
    ChinaCEP Company GMP cert on record
  • TAPI NL BV
    Active DMF 21006 · latest filing Nov 2007
    NetherlandsCEP
  • Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
    Active DMF 23343 · latest filing Nov 2009
    ChinaCEP Company GMP cert on record
  • ACEBRIGHT INDIA PHARMA PRIVATE LTD
    Active DMF 26322 · latest filing Aug 2012
    India
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 24811 · latest filing Mar 2011
    India Company GMP cert on record
  • Formosa Laboratories, Inc.
    Active DMF 35153 · latest filing Oct 2020
    Taiwan Company GMP cert on record
  • Reliance Life Sciences Pvt. Ltd.
    Active DMF 24207 · latest filing Mar 2011
    India Company GMP cert on record
  • Sun Pharmaceutical Industries Limited
    Active DMF 19499 · latest filing Jun 2006
    India Company GMP cert on record
  • TAI HENG INDUSTRY GROUP CO LTD
    Active DMF 24838 · latest filing Mar 2011
  • CDYMAX (INDIA) PHARMA PRIVATE LIMITED
    IndiaCEP Company GMP cert on record
  • Deva Holding As
    CEP Company GMP cert on record
  • Intas Pharmaceuticals Ltd.
    Inactive DMF 32270 · latest filing Nov 2017
    IndiaCEP Company GMP cert on record
  • MAC CHEM PRODUCTS INDIA PVT LTD
    CEP
  • SYNTHIMED LABS PRIVATE LIMITED
    IndiaCEP Company GMP cert on record
  • Zhejiang Ausun Pharmaceutical Co., Ltd.
    ChinaCEP Company GMP cert on record
Need Imatinib Mesylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (18)

Certificates of Suitability on the EDQM register for Imatinib Mesylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 29 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MAC-CHEM PRODUCTS (INDIA) PRIVATE LIMITED MumbaiIN
CEP 2025-196 - Rev 00
Imatinib mesilate
Sept 2026—
HETERO LABS LIMITED HyderabadIN
CEP 2025-106 - Rev 01
Imatinib mesilate, FORM-β, ES Process
Sept 2026—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2026-126 - Rev 00
Imatinib mesilate, β-Form
Jul 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2025-099 - Rev 00
Imatinib mesilate, β-Form
Nov 2025—
ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2023-303 - Rev 01
Imatinib mesilate, Form-β
Nov 2025Inspected Jan 2024
Hungary
LAURUS LABS LIMITED HyderabadIN
CEP 2020-086 - Rev 02
Imatinib mesilate, Process II
Sept 2025—
CDYMAX (INDIA) PHARMA PRIVATE LIMITED BangaloreIN
CEP 2018-262 - Rev 02
Imatinib mesilate
Jul 2025Inspected Nov 2025
Switzerland
SHANDONG ANXIN PHARMACEUTICAL CO., LTD JinanCN
CEP 2017-292 - Rev 04
Imatinib mesilate, β form, milled, non-milled
Apr 2025Inspected Sept 2023
Austria, outside 3-year window
TAPI NL B.V. AmsterdamNL
CEP 2015-096 - Rev 05
Imatinib mesilate
Feb 2025—
INTAS PHARMACEUTICALS LIMITED AhmedabadIN
CEP 2018-047 - Rev 03
Imatinib mesilate, β-form
Jan 2025—
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou CityCN
CEP 2018-235 - Rev 02
Imatinib mesilate, Form α
Sept 2024Inspected Nov 2025
Hungary
SYNTHIMED LABS PRIVATE LIMITED DerabassiIN
CEP 2021-151 - Rev 01
Imatinib mesilate, Form-α
Aug 2024Inspected Aug 2026
Slovenia
MSN LABORATORIES PRIVATE LIMITED Kardanur VillageIN
CEP 2017-118 - Rev 01
Imatinib mesilate
Mar 2024Inspected Aug 2026
Slovakia
DEVA HOLDING A.Ş. IstanbulTR
CEP 2016-299 - Rev 01
Imatinib mesilate, α Form
Oct 2023—
NATCO PHARMA LIMITED HyderabadIN
CEP 2015-273 - Rev 01
Imatinib mesilate
Oct 2023—
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
R1-CEP 2016-058 - Rev 00
Imatinib mesilate
Aug 2022—
SHANDONG ANXIN PHARMACEUTICAL CO., LTD. Dongjia TownCN
R1-CEP 2016-039 - Rev 00
Imatinib mesilate
Jun 2022—
CIPLA LIMITED MumbaiIN
R1-CEP 2015-230 - Rev 00
Imatinib mesilate, Alpha form
May 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Imatinib Mesylate are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • SIGNA SA DE CV
    Inactive DMF 28192 · filed Jun 2016
  • Kyongbo Pharmaceutical Co., Ltd.
    South · Inactive DMF 28511 · filed Jul 2014
  • India · Inactive DMF 27669 · filed Dec 2013
  • China · Inactive DMF 26606 · filed Dec 2012
  • Sichuan Xieli Pharmaceutical Co Ltd
    China · Inactive DMF 26362 · filed Aug 2012
  • PHF SA
    Inactive DMF 24287 · filed Dec 2010
  • MYLAN LABORATORIES LTD
    Inactive DMF 23139 · filed Oct 2009

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Imatinib Mesylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1642).

Chemical identity

IUPAC name
methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
Canonical SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
InChIKey
YLMAHDNUQAMNNX-UHFFFAOYSA-N
Synonyms
Gleevec, Glivec, Imatinib accord, Imatinib actavis, Imatinib (as mesilate), Imatinib koanaa, Imatinib medac, Imatinib mesilate, Imatinib mesylate, Imatinib methane sulfonate, Imatinib methanesulfonate, Imatinib teva

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Kinase Inhibitor
Mechanism of action
Bcr-Abl Tyrosine Kinase Inhibitors; Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A4 Inhibitors; Protein Kinase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Imatinib Mesylate?

24 organisations hold an active US FDA Type II Drug Master File or a CEP for Imatinib Mesylate: FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Hetero Labs Limited (India), Laurus Labs Limited (India), MSN Laboratories Private Limited (India), SHILPA PHARMA LIFESCIENCES LTD (India), Zydus Lifesciences Limited (India), APITORIA PHARMA PRIVATE LTD (India) and Cipla Limited (India), and 16 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Imatinib Mesylate Drug Master Files are active?

FIS FABBRICA ITALIANA SINTETICI SPA (DMF 25205, 25206), Hetero Labs Limited (DMF 26687, 25116), Laurus Labs Limited (DMF 27089, 33312), MSN Laboratories Private Limited (DMF 26386, 32394), SHILPA PHARMA LIFESCIENCES LTD (DMF 27927, 28349), Zydus Lifesciences Limited (DMF 34476, 30871), APITORIA PHARMA PRIVATE LTD (DMF 36238) and Cipla Limited (DMF 26170, 28333) and 10 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Imatinib Mesylate records mean?

7 organisations have only inactive Type II DMFs for Imatinib Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Imatinib Mesylate have a European Certificate of Suitability?

Yes. 17 organisations hold a valid CEP for Imatinib Mesylate on the EDQM register, including MAC-CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai (IN), HETERO LABS LIMITED Hyderabad (IN), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Taizhou (CN) and LAURUS LABS LIMITED Hyderabad (IN) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Imatinib Mesylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Imatinib Mesylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.